Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma

SUMMARY: We observed a novel therapeutic response with cabergoline in a male patient with a dopamine-secreting head and neck paraganglioma (HNPGL), macroprolactinoma and germline succinate dehydrogenase C mutation (SDHC). The macroprolactinoma was treated with cabergoline which gave an excellent res...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Ziad, Korbonits, Marta, Baldeweg, Stephanie E, Chung, Teng-Teng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Unusual Effects of Medical Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240717/
https://www.ncbi.nlm.nih.gov/pubmed/34110302
http://dx.doi.org/10.1530/EDM-21-0003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240717/
https://www.ncbi.nlm.nih.gov/pubmed/34110302
http://dx.doi.org/10.1530/EDM-21-0003

Ejemplares similares